Tasly Pharmaceutical Group Co. Ltd.SSE: 600535

Announcement on Convening the 2026 Semi-annual Performance Briefing

· Issued by Tasly Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

The briefing will take place on a specified date and will be conducted in an interactive online format. Company executives will participate to discuss the company's operational results and financial indicators with investors. Investors can submit questions prior to the event through designated platforms.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Tasly Pharmaceutical Group Co. Ltd. on 6ix

Earlier from Tasly Pharmaceutical

Later from Tasly Pharmaceutical

All Tasly Pharmaceutical news releases